# Faster childhood growth doesn’t answer an older adult’s health questions > Sermorelin | Growth Hormone Axis research peptides — Growth Hormone Axis research peptides involve linked hormones. Sermorelin helped children grow; adult sleep, fat loss and aging claims need their own tests. **02 / GROWTH IN CHILDREN** A trial measured children’s yearly growth. Other papers gave doctors’ views or tested another drug. An axis means the hormones involved work together. ## The plain answer concerns children with too little growth hormone Scientists measured yearly height gain in children with low growth hormone. The children grew faster when given the hormone piece represented by sermorelin [11]. Sermorelin can prompt the body to send growth hormone into blood. The body also keeps its own means of slowing that release. The children's trial doesn't answer your questions about sleep, strength or fat loss. The children had a hormone shortage before treatment began, and scientists measured their height gain in centimeters per year, so their result doesn't answer a question about sleep or energy in healthy adults. Blood readings alone couldn't provide those missing answers either. Two papers offered doctors' opinions about use in adults [9][10]. An opinion can explain why a treatment seems worth testing. Another trial tested tesamorelin, a different drug, in older adults [8]. A result with that drug cannot prove the same benefit from sermorelin. Sermorelin's effect on hormone release is better established than broad adult benefits. Childhood growth provides direct evidence for the earlier use. Claims about better sleep or slower aging need studies of those outcomes. You cannot carry a child's growth result over to healthy older adults. ## Prescriptions today differ from the earlier approved childhood product Sermorelin copies twenty-nine amino acids, the tiny pieces that make a protein or peptide. The natural hormone has forty-four such pieces and starts growth hormone release. This smaller copy can still prompt the gland to send growth hormone into blood. Scientists also changed the copy's end. Sermorelin once had United States approval for a childhood growth problem. That approval concerned children who had too little growth hormone. The approved product later left the market for business reasons. That withdrawal didn't follow a demonstrated failure of safety or benefit. A doctor can prescribe a preparation made by a pharmacy today. Pharmacy preparation doesn't give that product the earlier approval or approval for adult aging claims. The former childhood use cannot tell you whether an adult prescription will help. ## Natural controls on hormone release don’t remove possible harms Sermorelin prompts the pituitary gland beneath the brain to send growth hormone into blood. The liver then makes another hormone that supports growth. The body sends messages that slow release as hormone levels rise. A review describes these hormones and the body's controls on release [1]. Two thousand six: a doctor argued for prompting the gland [10]. The doctor thought this might follow natural bursts better than giving growth hormone directly. That paper offered a view of how treatment might work. The paper wasn't a trial showing that patients became healthier. Two thousand eight: another doctor questioned use of these drugs for aging [9]. The body's controls don't guarantee safe blood hormone levels. Possible concerns include higher blood sugar, swelling from retained water and unwanted tissue growth. You cannot assume a natural slowing response removes those concerns. ## Children grew faster; the older adult trial tested tesamorelin Nineteen ninety-six: children with low growth hormone joined a study at several centers [11]. Before puberty, growth rose from about 4.1 centimeters per year to roughly 7 to 8 centimeters per year during the first treatment year. IGF-1, a hormone that helps tissues grow, didn't rise excessively in those children. Faster growth during that year didn't establish final adult height. The children began with too little growth hormone. The trial measured their height gain after treatment. The result cannot predict fat loss or improved energy in healthy adults. Your age and the benefit you want require a different test. Two thousand twelve: one hundred fifty-two older adults took tesamorelin for twenty weeks [8]. Sixty-six had mild trouble with memory or thinking. Overall thinking test results improved with that other drug. IGF-1 rose one-hundred-seventeen percent, more than doubling, while remaining within the normal range. Body fat had a 7.4-percent fall from its starting amount. That wasn't a fall of the same share of total body weight. The normal hormone range allows different readings, so a large rise can remain within that range when the person's blood reading began near the lower end rather than the upper end. Those findings concern tesamorelin and cannot establish a benefit from sermorelin for you. Two thousand six: an opinion paper favored keeping natural bursts and controls on release [10]. Two thousand eight: another opinion paper found insufficient evidence for treating aging [9]. Neither paper tested those adult claims by comparing treated people with untreated people. The opinions leave benefits for aging unproven. ## Sleep reports leave both benefit and safety uncertain **People trying the drug as an experiment describe these changes; trials comparing people with and without treatment haven't confirmed the accounts.** The accounts don't say whether users took part in a study or had medical care. Reports describe vivid dreams, deeper sleep, steadier energy and gradual fat changes. Some describe better recovery without saying from what; others report little or no change. People also report redness or itching where a shot went in. Other reports mention headache, dizziness, nausea, puffiness and appetite changes. Flushing means a sudden warm feeling with skin redness, often on the face. Some accounts also mention grogginess, tingling or changed blood sugar. Other treatments, expectations and uncertain bottle contents may affect those experiences. You cannot tell which changes sermorelin caused or how common the changes were. An opinion paper challenged use of these drugs for aging [9]. Lasting improvements in adult health remain unproven. Hormones involved in growth affect blood sugar and can cause concern about retained water and swelling. Scientists also question whether higher hormones could encourage an unwanted growth already present. The studies cannot tell you how often those problems might happen. Sermorelin also breaks the rules in sport that tests competitors for these drugs. ## Sermorelin’s own findings can’t borrow another drug’s benefits Sermorelin copies a smaller piece of the hormone that starts growth hormone release. [CJC-1295](/cjc-1295) with a blood protein attachment lasts longer. [Tesamorelin](/tesamorelin) copies more of that natural hormone and has trials for a specific fat problem. [Ipamorelin](/ipamorelin) prompts release through the appetite hormone instead. The childhood sermorelin findings concern children with a hormone shortage [11]. The older adult thinking and fat findings came from tesamorelin [8]. Doctors' opinions explain hopes and concerns without proving benefits in adults [9][10]. Similar effects on hormones don't give you the same health results. The [comparison](/compare) sets out what happened with each drug. Your question about sleep or strength needs tests of sleep or strength. Childhood height gain cannot answer either question in an older adult. An adult benefit remains uncertain until adults have that benefit in trials. ![Sermorelin research illustration with abstract endocrine signaling motifs](/images/sermorelin.webp) --- An independent GH-axis measurement review that preserves each study’s units and limits; it is neither a dose calculator nor medical advice.